Roßwag, S., Cotarelo, C. L., Pantel, K., Riethdorf, S., Sleeman, J. P., Schmidt, M., & Thaler, S. (2021). Functional characterization of circulating tumor cells (CTCs) from metastatic ER+/HER2− breast cancer reveals dependence on HER2 and FOXM1 for endocrine therapy resistance and tumor cell survival: Implications for treatment of ER+/HER2− breast cancer. Cancers, 13(8), . https://doi.org/10.3390/cancers13081810
Chicago-Zitierstil (17. Ausg.)Roßwag, Sven, Cristina L. Cotarelo, Klaus Pantel, Sabine Riethdorf, Jonathan P. Sleeman, Marcus Schmidt, und Sonja Thaler. "Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer." Cancers 13, no. 8 (2021). https://doi.org/10.3390/cancers13081810.
MLA-Zitierstil (9. Ausg.)Roßwag, Sven, et al. "Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer." Cancers, vol. 13, no. 8, 2021, https://doi.org/10.3390/cancers13081810.